logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

Top 3 Largecap Stock Picks for March 2026 by Experts

APOLLOHOSP

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

Ask AI

Ask AI

Market Rebound Spurs New Trading Opportunities

As Indian equity markets signal a potential rebound after a sharp selloff triggered by geopolitical uncertainties in West Asia, domestic brokerage firm Master Capital Services has identified three largecap stocks with favourable technical setups. The firm suggests trading opportunities in Aurobindo Pharma Ltd, Apollo Hospitals Enterprise Ltd, and Coal India Ltd, based on recent price action and chart patterns.

Aurobindo Pharma: Holding a Key Breakout Level

Aurobindo Pharma is demonstrating significant strength by holding firmly above the critical breakout level of Rs 1,250. The stock's recent trading activity has been supported by solid volumes, which are noticeably above recent averages. A key development for the stock was a successful retest of the Rs 1,275 breakout zone, followed by a bounce. This price action confirms the breakout's validity and suggests it is not a false move driven solely by momentum.

The broader recovery structure from its mid-2025 lows of Rs 1,020 remains intact, with a clear sequence of higher lows visible on the daily chart. Further supporting the bullish outlook, the Relative Strength Index (RSI) has crossed above its signal line, registering a fresh bullish crossover. Historically, this indicator has preceded meaningful upward moves in the stock. Based on this analysis, traders are advised to consider buying in the Rs 1,280-1,300 range for a potential move towards Rs 1,350-1,400 in the short term. A stop loss below Rs 1,220 is recommended to manage downside risk.

Apollo Hospitals: A Structural Shift to Bullish

Apollo Hospitals is staging an impressive recovery from its horizontal support level at Rs 7,200. The most significant recent event is the stock's breakout above a falling trend line that had capped recovery attempts since November 2025. This structural shift changes the near-term bias from bearish to cautiously bullish. The RSI, while not yet in full momentum territory, is attempting a positive crossover from an extended base, indicating a potential turn in momentum.

As a leading private healthcare provider in Asia, Apollo Hospitals operates a vast network of specialty hospitals, clinics, and pharmacies. The company's strong fundamentals, including its position as a market leader in the sector, provide a solid backdrop to the technical buy signal. The brokerage suggests traders consider buying the stock in the Rs 7,300-7,400 zone. The potential short-term targets are set at Rs 7,800-7,900, with a recommended stop loss at Rs 7,090.

Coal India: Healthy Pullback within an Uptrend

Coal India has broken out of a rising channel and is currently in a retracement phase, pulling back toward the channel's upper boundary, which is now expected to act as support. This pattern is considered a healthy pullback within a larger uptrend. The stock's price remains above key moving averages, and it continues to form a higher-high, higher-low structure, which is characteristic of a sustained uptrend.

The initial breakout was supported by a strong expansion in trading volume, while the current retracement is occurring on relatively lower volumes. This suggests that the selling pressure is controlled profit-booking rather than a reversal, supporting the likelihood of the uptrend continuing. The RSI also remains in the bullish zone, reflecting sustained momentum. Traders are advised to look for buying opportunities in the Rs 464-470 range, with potential upside targets of Rs 525-550. A stop loss is suggested below Rs 440.

Summary of Recommendations

Here is a quick summary of the trading calls from Master Capital Services:

Stock NameRecommendationBuy Range (Rs)Target Price (Rs)Stop Loss (Rs)
Aurobindo PharmaBuy1,280 - 1,3001,350 - 1,4001,220
Apollo HospitalsBuy7,300 - 7,4007,800 - 7,9007,090
Coal IndiaBuy464 - 470525 - 550440

Investment Strategy and Risk Management

The recommendations are based on technical analysis and are intended for a short-term trading perspective. The brokerage has clearly defined entry zones, targets, and stop-loss levels for each stock. Adhering to the stop-loss levels is crucial for managing risk, especially in a market that is recovering from volatility. These levels are designed to protect capital in case the anticipated price moves do not materialize. Investors should consider these technical setups in conjunction with their own risk appetite and investment goals before making any trading decisions.

Frequently Asked Questions

Master Capital Services has recommended buying Aurobindo Pharma, Apollo Hospitals Enterprise Ltd, and Coal India from a short-term trading perspective.
The target price for Aurobindo Pharma is between Rs 1,350 and Rs 1,400, with a recommended stop loss below Rs 1,220.
Apollo Hospitals is recommended due to its recovery from a key support level and a significant breakout above a falling trend line, which indicates a structural shift from a bearish to a cautiously bullish trend.
The brokerage advises considering buying Coal India in the zone of Rs 464-470, as it is undergoing a healthy pullback within a larger uptrend.
No, these recommendations are based on technical analysis and are intended for short-term trading. They come with specific target prices and stop-loss levels for risk management.

A NOTE FROM THE FOUNDER

Hey, I'm Aaditya, founder of Multibagg AI. If you enjoyed reading this article, you've only seen a small part of what's possible with Multibagg AI. Here's what you can do next:

It's all about thinking better as an investor. Welcome to a smarter way of doing stock market research.